A 41-year-old Japanese man presented in October 2013 with a 2-week history of pruritic, erythematous papules. He had diabetes mellitus, hyperlipidemia, and hypertriglyceridemia, but had stopped treatment 5 years prior to this visit. He also suffered from acute pancreatitis, and was admitted to the Department of Medicine, Japan Community Healthcare Organization Osaka Hospital, 1 day prior. Topical steroid ointment prescribed during a previous visit to another clinic was ineffective for the treatment of the papules. At the time of consultation, he presented with multiple, approximately 5-mm, pruritic, yellowish, erythematous papules on the trunk and extensor surfaces of the extremities (Fig. 1A) . Dermoscopic examination of the papules clearly revealed granular yellowish characteristics (Fig. 1B) . The laboratory findings (normal values are in parentheses) were: white blood cell count, 13.3×10 3 (4.0×10 3 ∼8.5×10
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